← Back to Clinical Trials
Recruiting NCT06857669

NCT06857669 Clinical Explorative Optical Breast Investigations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06857669
Status Recruiting
Phase —
Sponsor Region Skane
Condition Benign Breast Tumors
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2020-12-01
Primary Completion 2026-12-31

Trial Parameters

Condition Benign Breast Tumors
Sponsor Region Skane
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2020-12-01
Completion 2026-12-31
Interventions
Diffuse reflectance spectroscopy and Photoacoustic imaging,

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study evaluates diffuse reflectance spectroscopy and photoacoustic imaging for differentiating healthy, benign, and malignant breast tissue by identifying their optical profiles.

Eligibility Criteria

Inclusion Criteria: * solitary malignant or benign biopsy verified tumour \> 1 cm * understands written and oral Swedish Exclusion Criteria: * previous breast surgery * has received neoadjuvant chemotherapy * skin burns in on the chest

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE BENIGN BREAST TUMORS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology